Clarification the role of Aurora-A in renal cell carcinoma and development of novel treatment for it
Project/Area Number |
23791755
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Urology
|
Research Institution | Kobe University |
Principal Investigator |
TERAKAWA Tomoaki 神戸大学, 大学院・医学研究科, 医学研究員 (50533759)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Keywords | 腎癌 / Aurora-A / 腎細胞癌 / AURORA-A |
Research Abstract |
The suppression of Aurora-A expression using shRNA is a useful therapeutic strategy against RCC through growth inhibition as well as enhanced chemosensitivity.
|
Report
(3 results)
Research Products
(2 results)